Last reviewed · How we verify
NCT05445414
A Mobile App Serious Game to Increase Awareness of Antibiotic Use in the Community
NA trial testing "SteWARdS Antibiotic Defense" app in Antimicrobial Resistance in 480 participants. Completed in 31 August 2023.
29 May 2023
Quick facts
| Lead sponsor | Tan Tock Seng Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 480 |
| Start date | 4 January 2022 |
| Primary completion | 29 May 2023 |
| Estimated completion | 31 August 2023 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- "SteWARdS Antibiotic Defense" app
Conditions studied
- Antimicrobial Resistance — all drugs for Antimicrobial Resistance →
Sponsor
Tan Tock Seng Hospital
Who can join
Adults 18 to 65, any sex, with Antimicrobial Resistance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The widespread and unnecessary use of antibiotics has encouraged the growth of antibiotic-resistant bacteria which can cause hard-to-treat and deadly infections. These infections are due to antimicrobial resistance (AMR). The public's lack of knowledge on the indication for and proper use of antibiotics often leads to unnecessary patient demands and subsequent misuse of antibiotics. Traditional mass public educational efforts through the use of brochures, posters and advertisements are extensive in outreach but questionable in effectiveness in improving the general public's knowledge on appropriate antibiotics use and AMR. Serious games app provides an additional venue for public education outreach to the population since a substantial amount of time is spent using smartphones. The use of serious games is expected to increase user engagement in learning, which will lead to short- and long-term improvements in knowledge, attitudes and perceptions on the appropriate use of antibiotics. The study team has co-developed an evidence-based serious game app- "SteWARdS Antibiotic Defense" -with Temasek Polytechnic. Users will be brought on a quest to learn about antibiotic use and AMR through mini-games and the bite-sized information released throughout the game quest. We intend to clinically validate our evidence-based app and improve its application with actual participants' feedback on its usage. Hence, this study aims to evaluate the effectiveness of an evidence-based serious game mobile application (SteWARdS Antibiotic Defense) in improving the knowledge on, attitude towards, and perception (KAP) of appropriate antibiotic use and AMR among Singaporeans. The primary objective is to assess the change in knowledge on antibiotic use and AMR among the app users compared with the control group. The secondary objectives are to:1) Assess the extent of user engagement of the app by evaluating the users' average screen time per day; and 2) Assess the level of user satisfaction in using the app for learning through a user satisfaction survey.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
An Evidence-Based Serious Game App for Public Education on Antibiotic Use and Resistance: Randomized Controlled Trial.
Huang Z, Ow JT, Tang WE, Chow A. · · 2024 · cited 2× · PMID 39235853 · DOI 10.2196/59848 -
An Evidence-Based Serious Game App for Public Education on Antibiotic Use and Antimicrobial Resistance: Protocol of a Randomized Controlled Trial.
Huang Z, Tang WE, Guo H, Natarajan K, et al · · 2023 · cited 1× · PMID 36976619 · DOI 10.2196/45833
Verify or expand the search:
- PubMed search for NCT05445414
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Antimicrobial Resistance
Currently open trials in the same condition.
- NCT07234331 — A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes. · recruiting
- NCT06436690 — Optimizing Antibiotics Prescription · NA · active not recruiting
- NCT06566898 — Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia Patients · recruiting
- NCT06358872 — Azithromycin for Child Survival in Niger II · Phase 4 · recruiting
- NCT05296837 — Ocular Rosacea Biome Study · Phase 4 · active not recruiting
Other Tan Tock Seng Hospital trials
Trials by the same sponsor.
- NCT07078240 — Examining Nurses' Trust and Acceptance of FAIR, an AI-powered Falls Risk Recommender · NA · not yet recruiting
- NCT07257341 — Pilot Study of Normative Range of Field of Binocular Single Vision in Adults in Singapore · recruiting
- NCT07151729 — Use of Anodal tDCS to Enhance Upper Limb Recovery in Stroke · NA · recruiting
- NCT07122752 — Feasibility and Outcomes of 3D-printed External Cranial Orthosis After Craniectomy · active not recruiting
- NCT07255859 — CRYSTALSIGHT Cohort 2.0 · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05445414 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tan Tock Seng Hospital
- Last refreshed: 18 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05445414.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing